Download Curriculum Vitae

2014 長庚紀念醫院微創胸腔手術國際研討會
林口長庚紀念醫院 復健大樓第一會議廳
Topic
Speaker
December 13, 2014,
Time
07:30~8:20
Registration
Hui-Ping Liu
Yun-Hen Liu
Session 1: 胸腔手術進展(Advance in Thoracic Surgery )
Yoshiya Toyoda
Current status in Lung transplantation
Technical consideration in VATS lobectomy
Jun Wang
08:30~10:00 Trouble shooting in complicated VATS esophagectomy Hiroyuki Daiko
Trick and Treat in VATS
Hui-Ping Liu
Discussion
10:00~10:30 BREAK
Session 2: 機器手臂胸腔手術 (Robotic thoracic surgery)
08:20~8:30
Moderator
Opening
Jun Wang
Liang-Shun Wang
Chung-Ping Hsu
Jang-Ming Lee
Yi-Cheng Wu
Recent advances in robotic surgery in esophageal cancer Dae Joon Kim
Robotic surgery of the lung in Taiwan
Robotic surgery of the esophagus in Taiwan
10:30~12:00
Robotic surgery of the mediastinum in Taiwan
Robotic training and resident education in thoracic
surgery
Discussion
Jang-Ming Lee
Chih-Cheng Hsieh
Ying-Chieh Su
Han-Shui Hsu
Yao Fong
Wu-Wei Lai
Ming-Ju Hsieh
Yu-Jen Cheng
Cheng-Yen Chuang Jiun-Yi Hsia
Ming-Shian Lu
Session 3: 單一傷口胸腔鏡手術 (Single Port VATS)
Gonzalez Rivas
Recent Advances in uniport surgery
Diego
Nonintubated Uniport thoracoscopic surgery
Jin-Shing Chen
Hung Chang
Chia-Chuan Liu
12:30~14:00 Uniport video-assisted thoracoscopic surgery
Chin-Yuan Cheng
Hung-I Lu
Uniport subxyphoid approach in thoracic surgery
Wei-Cheng Lin
12:00~12:30 Lunch symposium
Uniport surgery in thoracic disease using flexible
videoscopy
Discussion
14:00~14:30 BREAK
Tzu-Ping Chen
Session 4: 自然孔腔胸腔手術 (NOS in thoracic surgery)
POEM in Japan
Hironari Shiwaku
POEM in China
Ping-Hong Zhou
14:30~16:00 ENB in thoracic disease
Hao Wang
Transumbilical thoracic surgery in human
Wei-Sheng Chen
Transumbilical thoracic surgery in lab
Yun-Hen Liu
16:00~16:30 BREAK
Session 5: 其他 (Miscellaneous)
Database management in lung cancer
Sanghoon Jheon
Database management in esophageal cancer
Yin-Kai Chao
16:30~17:30
The new frontiers in minimally invasive thoracic surgery Anthony PC Yim
Discussion
Shah-Hwa Chou
Hsin-Yuan Fang
Yu-Chung Wu
Yih-Gang Goan
Wen-Chieh
Huang
Ching Tzao
Building Successful Lung Transplantation Programs – Role of Minimally Invasive Antero-Axillary Approach
Temple University School of Medicine, Philadelphia, PA, USA
Yoshiya Toyoda
I have had the privilege to work as the surgical director in lung transplantation with my talented, hard-working
colleagues at both a large and a small center in the US over the past decade. We were successful in transforming an
already large center to the largest center in the world, and an inactivated, small center to one of the largest centers
with one of the best outcomes in the US. We have seen an inherent risk in increasing volume as possible poor
outcomes due to the acceptance of high risk recipients and donors. At my former center, our lung transplant volume
increased from 58 in 2004, to 87 in 2005 and 93 in 2006. However, the 1-year graft survival decreased from 87% to
76%. Afterwards, we were able to improve it to 88% while further increasing volume (Figure 1). To improve
outcomes, we developed a less invasive approach to perform lung transplantation. We named it as “antero-axillary
approach.” Our standard approach for single lung transplantation changed from postero-lateral approach to
antero-axillary approach and for double lung transplantation from clamshell approach to antero-axillary approach.
These lessons helped in the building of my current program. Our Temple lung transplant program was inactivated in
2011 due to poor outcomes and low volume. Since then, the program was re-activated in 2012, and our annual lung
transplant volume increased from 7 to 21 to 44 (Figure 2). The number of our active patients on the wait-list
increased from 13 to 37 from 2012 to 2013. We have extended the recipient selection criteria. In 2013, 48.1% of our
recipients were age 65 years and older, and 14.8% were with a body mass index higher than 31. While increasing
volume, we were able to improve our outcomes as well (Figure3). I would like to share my experiences with our
colleague in Taiwan.
Thoracosopic Esophagectomy in the Prone Position including Trouble Shooting.
National Cancer Center Hospital East, Chiba, Japan
HIROYUKI DAIKO
Despite the recent advance in thoracoscopic techniques for carcinoma of the esophagus, transthoracic
esophagectomy is still standard operative approach in Japan. In my institution, thoracoscopic esophagectomy in the
prone position (TSEP) was started from 2008 only for clinical stage I carcinoma of the esophagus at that time.
However, TSEP has been gradually adapted to more advanced disease. Latest indication of TSEP is clinical T1-3
excluding patients with failure after definitive chemoradiotherapy at the present time. More than 300 patients with
carcinoma of the esophagus were underwent TSEP, three of them were converted to open approach because of the
intraoperative trouble caused by energy device.
Recently, magnifying observation using endscopy is more focused on thoracoscopic surgery for carcinoma of the
esophagus. There is no patient who is converted to open approach from 2012, when TSEP can be performed with
magnifying observation. Thoracoscopic esophagectomy based on the magnifying observation has advantages for the
safety, curability and excellent QOL.
Recent Advances In Robotic Surgery In Esophageal Cancer
Severance Hospital
Yonsei University College of Medicine
Seoul, Korea
Dae Joon Kim
Since the first successful robotic esophagectomy was reported in 2004, there have been several case reports from
US, Europe, and Asia. We can observe some differences in their approaches and technical details between Western
countries and East Asia. This is mainly due to the differences in tumor histology, body habitus, incidence of GERD,
and a strategy of lymph node dissection. Although we expect the better early outcome in robotic esophagectomy
series, there has been no evidence to prove this. In 2012, a randomized controlled trial which compares the outcome
of robotic esophagectomy and open esophagectomy (ROBOT trial) has been started, and we hope that this trial will
tell us the answer.
From technical point of view, there have been a gradual improvement of da Vinci system (Intuitive Surgical, US)
from da Vinci (with 3 arms) to da Vinci Si over a decade. We have seen the improvement of imaging quality,
maneuverability as well as the education environment because of an assistant console. In my experience, robotic
surgery for esophageal cancer can offer the following advantages as compared to VATS esophagectomy ; (1)
learning the procedure is faster, (2) dissection of the upper mediastinum is easier, (3) no experts are required for
assistance, (4) teaching our trainees is more efficient.
However, there are some issues that should be addressed. Firstly, recent series from Korea and Japan failed to
demonstrate a significant decrease in the incidence of vocal cord palsy. Second, considering that no studies could
prove the shorter hospital stay, one can argue its higher installation and maintenance costs. NIR-image guided
surgery and a newer platform may solve these problems.
As mechanical engineering and information technology evolve, it is very difficult to expect that we will continue
esophagectomy under current VATS system in 10-20 years later. I think we are experiencing a paradigm shift from
traditional endoscopic surgery to a certain type of future surgery. It is a duty of our generation to develop a better
technique with newer system and to educate our trainees.
Robot-assisted Thoracic Surgery
Jang-Ming Lee MD
Departments of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine,
7 Chung-San South Road, Taipei 100, Taiwan
Minimally invasive surgery using thoracoscopy have been gradually adopted to be an effective surgical approaches
to treat various thoracic disease. However, 2D-imaging system and limitation in instrument manipulation through a
small port has long been criticized by some surgeons. With the novel robotic surgical system using 3-D high
definition imaging and 7-degree of freedom for instrumentation, many thoracic surgical procedures have been
reported to been safely and effective performed, including lobectomy, thymothymectomy and esophagectomy.
From February 2012 to Oct 2014 . We performed 123 cases of robotic-assisted thoracic surgery including
thymothymectomy (10), lobectomy or segmentectomy (99), esophagectomy or excision of esophageal tumor (14).
We found it was especially useful for the lesion with difficult approach or requiring complex procedure such as
bronchoplasty. From our limited experience, robot-assisted thoracic surgery is feasible and safe and can provide the
patients of thoracic disease with difficult approach or requiring complex procedure the chance to be treated with
minimally invasive surgery. However, it role in thoracic surgery especially for the long term treatment outcome
required to be examined in the future.
Robotic surgery of the esophagus—the Experience of Taipei Veterans General Hospital
Chih-Cheng Hsieh, M.D.
Division of Thoracic Surgery, Department of Surgery, Taipei-Veterans General Hospita
From Nov. 2010, there were 30 patients received robotic surgery for esophageal diseases in Taipei-Veterans General
Hospital. Except 2 patients with achalasia, the other (28/30) patients had esophageal cancer. All patients were male
and the mean age was 58.9 years, ranging from 47 to 84 years. The tumors in most patients were near the carina level
and 11 patients received pre-operative concurrent chemoradiotherapy. There were 3 patients received robotic gastric
tube preparation and 5 laparoscopic preparation. The average console time in thoracic phase was about 2.5 hours and
blood loss was 226ml. Post-operative lengths of stay were 18.7 days.
There was 1 case converted to minithoracotomy due to huge tumor. One patient had azygos vein injury with bleeding
and repaired using robotic instruments. There were several post-operative complications, included hoarseness,
chylothorax, neck lymph leakage, anastomosis leakage, prolonged ventilator use and gastroparalysis.
In our initial experience of robotic surgery for esophagectomy, the convert rate and hospital stay were not higher
than those of VATS at least. Robotic assisted thoracoscopic surgery is feasible and worth to evolve continuously.
Robotic surgery of the mediastinum in Taiwan.
Ying-Chieh Su, M.D.
Department of thoracic surgery, Chimei medical center
Abstract
RATS (Robot assisted thoracoscopic surgery) had a burst progress in Taiwan since 2012. Over 400 RATS were
practiced in Taiwan. Among them, 37 cases were mediastinal tumor surgery. In Chimei medical center, we
performed 16 cases of RATS mediastinal surgery. Half of them were extended thymothymectomy.
High degree of freedom of the da Vinci robot instrument made it widely used in surgery in small space like pelvis.
The same situation happened in mediastinal surgery. With our surgical experiences, we found da Vinci robot made
extended thymothymectomy more practical. It’s technically easy and safe. And we feel more confident about the
cleanliness thymothymectomy.
We’d like to show some short term outcomes and technical details in robotic surgery of the mediastinum.
Expandable stents for esophageal lesion
Cheng-Yen Chuang, MD.
Division of Thoracic Surgery, Surgical department, Taichung Veterans General Hospital
Expandable metal stents are very often used for esophageal lesions, especially in esophageal cancer patients who
cannot receive surgical intervention. Other indications include esophageal stricture caused by intrinsic and/or
extrinsic malignant tumor compression, or esophageal fistula. The long term usage of metal stent in benign lesion is
contraindicated. In such situation, hybrid stent (mix silicone and metal) is more suitable.
Before placing stents, identifying the esophageal lesions and choose correct stents are very improtant. Covered stent
? Non-covered stent ? Proximal release ? Distal release ? are key points in selection of proper stents. The placement
of an esophageal stent has several steps: Visualizing, Measuring, Marking, and Deployment. After stent placement,
adequate follow-up and instructions for oral intake are mandatory.
There several potential complications for stents placement: perforation; stent migration; tumor over growth at the
end of the stent or in-growth through the stent; food impaction; tracheal compression; and pain. Proper
management will increase the satisfaction and promote the quality of life of patients.
RECENT ADVANCES IN UNIPORTAL VATS SURGERY
Diego Gonzalez-Rivas, MD, FECTS
Thanks to the recent improvements in thoracoscopy, a great deal of complex lung resections can be performed
without performing thoracotomies. During the last years, experience gained through video-assisted thoracoscopic
techniques ,enhancement of the surgical instruments and improvement of high definition cameras have been the
greatest advances. The huge number of surgical videos posting on specialized websites, live surgery events and
experimental courses has contributed to the rapid learning of minimally invasive surgery during the last years.
Nowadays, complex resections are being performed by thoracoscopic approach in experienced centers.
Additionally, surgery has evolved regarding the thoracoscopic surgical approach, allowing us to perform difficult
procedures by means of a small single incision, with excellent postoperative results.
Uniportal video-assisted thoracic surgery (VATS) has a history spanning over more than 10 years and, more
recently, has become an increasingly popular approach to manage most of the thoracic surgical diseases. The
potential advantages of reduced access trauma and better cosmesis, together with patient demand, have seen uniportal
VATS spread across the world. Since we developed the uniportal technique for VATS major pulmonary resections in
2010 we have increased the application of this technique to more than 95% of cases in our routine surgical practice.
The experience we acquired with the single port technique during the last years, as well as technological
improvements in high definition cameras, development of new instruments, vascular clips and more angulated
staplers have made this approach safer, incrementing the indications for single-port thoracoscopic resections. We
believe it is important to minimize the surgical aggressiveness especially in advanced stage lung cancer patients
where the immune system is weakened by the disease or by induction treatments. The minimally invasive surgery
represents the least aggressive form to operate lung cancer and the single-port or uniportal technique is the final
evolution in these minimally invasive surgical techniques.
The future of the thoracic surgery is based on evolution of surgical procedures and innovations to try to reduce even
more the surgical and anesthetic trauma. We truly believe on the use of the single port technique combined with
future robotic technology for major pulmonary resections because we understand that the future goes in the direction
of digital technology which improve the adoption of single port technique worldwide in the next coming years.
The current DaVinci robotic technology has been around for over a decade. Despite offering excellent visual
feedback and robotic arm dexterity and precision, several ports are still required for the lobectomy. Although
performing robotic surgery throughspecialized single-incision laparoscopic surgery (SILS) ports is possible with
computer-compensated movements to overcome the difficulties associated with instrument crossover, robotic SILS is
probably the limit for the current system design in terms of minimizing surgical access trauma. The main reason for
this limitation is simple; essentially the robot is ‘outside’ of the patient. To move forwards into a higher realm, the
whole robotic approach needs to be revised. To perform complex robotic thoracic surgery through a single small
incision, the robot’s ‘shoulders’, ‘arms’ and ‘head and eyes’ must move inside the thoracic cavity with parallel
instrumentations, making the procedure more anatomic and easy.
Recent innovations in single port approach are the use of subxyphoid technique and the thoracoscopic lobectomy in
non intubated patients. Liu et al from Taiwan successfully performed the first cases of uniportal VATS lobectomies
via a subxyphoid approach, which might reduce the risk of intercostal nerve injury and avoids the limitations
imposed by narrow rib spaces. One of the limitations of this approach are the transmitted pulsation from the heart to
the VATS instruments and the difficulties to control a bleeding from upper lobe tumors. Interestingly, an additional
advantage of the subxyphoid approach is the ability to gain access to bilateral thoracic cavities to perform bilateral
lung resections through a single incision
We expect further development of new technologies like sealing devices for all vessels and fissure, robotic arms that
open inside the thorax and wireless cameras, which will probably allow the uniportal approach to become the
standard surgical procedure for major pulmonary resections in most thoracic departments. We recently introduced in
our department the uniportal VATS lobectomy tecnnique in non intubated patients. The combination of nonintubated
or awake thoracoscopic surgery and single-port VATS technique is promising because it represents the least invasive
procedure for pulmonary resections. Thanks to avoidance of intubation, mechanical ventilation and muscle relaxants
the anesthetic side effects are minimal allowing to most of the patients to be included in a fast protocol avoiding the
stay in a intensive care unit. Given that only one intercostal space is opened, the use of local anesthesia and blockade
of a single intercostal space is enough for pain control at the beginning and during the surgery (no epidural and no
vagus blockade is necessary in the single port approach). We use no trocar and during instrumentation we try to
avoid pressure on the intercostal nerve so we reduce the risk of intercostal bundle injury. This non intubated major
pulmonary resctions must only be performed by experienced anesthesiologists and uniportal thoracoscopic
surgeons (preferably skilled and experienced with complex or advanced cases and bleeding control through VATS).
Nonintubated Uniportal Thoracoscopic Surgery
Jin-Shing Chen, MD, PhD
Professor, Department of Surgery, National Taiwan University, Taipei, Taiwan
Director, Department of Traumatology, National Taiwan University Hospital and National Taiwan University
College of Medicine, Taipei, Taiwan
Abstract
Background. Uniportal video-assisted thoracoscopic surgery (VATS) is recently introduced for various thoracic
diseases. However, management of peripheral lung nodules by uniportal VATS, without tracheal intubation, has
rarely been attempted. We evaluated the feasibility and safety of nonintubated uniportal VATS for peripheral lung
nodules.
Methods. From January 2014 to October 2014, 110 patients with indeterminate peripheral lung nodules underwent
uniportal VATS with or without tracheal intubation. Computed tomography-guided dye-localization was used to
identify small or ground-glass opacity lesions.
Results. A definite diagnosis was obtained in all patients, of whom wedge resection was performed in 103,
segmentectomy in 5 and lobectomy in 2. Conversion to conventional 3-port VATS was required in 6 patients because
of primary lung cancer requiring further resection for adequacy of margins or difficulty in identifying the small
nodule. One patient required conversion to intubated one-lung ventilation because of vigorous mediastinal movement.
Operative complications developed in 4 patients who had an air leak for more than 3 days postoperatively. The mean
duration of postoperative chest tube drainage and mean hospital stay were 1.5 days and 3.0 days, respectively.
Conclusions. Nonintubated uniportal VATS are technically feasible and as safe as intubated uniportal VATS to
provide selected patients a less invasive alternative in managing their indeterminate peripheral lung nodules.
Uniport video-assisted thoracoscopic surgery
Chia-Chuan, Liu MD
Sun Yat-Sen Cancer Center, Taiwan.
LESS plays a very important role in recent development of minimally invasive surgery. From reduced ports to single
port surgery, rapid progression on design of surgical devices has been noted, e.g. 3-D camera system, 5mm
endostapler, articulate instruments, and these newly designed devices allow we surgeons more rooms to perform
more advance and delicate operations.
From simple wedge resection to anatomic lung resection, lymph node dissection, even sleeve resection, and
troubleshooting - as management of pulmonary artery bleeding, tumor after chemoradiation; single port VATS, just
like other multi-port VATS, has documented its feasibility and safety by many reports, and more importantly,
training program has been setup in some experienced centers.
What have we achieved from multiple port VATS to uniport VATS? We still lack of strong evidence on
periopearative outcome and pain study, and it is lessly like we are going to have survival advantage just by reducing
the number of port, however; we did reduced trauma to the patient and also regain the traditional baseball field
setting for endoscopic surgery, with camera in the center; and this is usually compromised during multi-ports VATS
- when camera was inserted on the mid or even posterior axillary at different lower intercostal space. In addition to
reduced trauma outside on the wound, several directions on single port surgery are aimed to further reduce trauma to
the patient, non-intubated single port surgery, aimed on reducing anesthesia induced trauma; sub-lobar resection
(segmentectomies /segmentectomy /subsegmentectomy) to preserve more lung parenchyma, and sub-xiphoid single
port surgery aimed on reducing post-operative neuralgia; also single port robotic system also available now, and
definitely will going to have rapid progression in some fields, thoracic surgery included. We are looking forwardly to
have more new ideas and data in the future in this era to bring more benefits to our patients.
Uniport subxyphoid approach in thoracic surgery
Wei-Cheng Lin, M.D.
Division of Thoracic Surgery, Department of Surgery, Wang Fong Hospital
Although conventional Video-Assisted Thoracoscopic Surgery (VATS) has been shown to provide better
post-operative recovery, in comparison to thoacotomy, there are still some disadvantages about this approach, such
as intercostal neuropathy. To overcome these disadvantages, we developed a novel subxyphoid approach, which
utilized single-port VATS technique, to accomplish a range of different thoracic surgical procedures.
By adopting this subxyphoid approach, we could perform operations in bilateral pleural cavity and peritoneal cavity
simultaneously via only one non-rib cage entry. Due to avoidance of injury at intercostal space, patients might be
free from both acute and chronic neuropathy. For primary spontaneous pneumothorax, 12 patients underwent this
subxyphoid single-port VATS from January to October 2014. The mean Visual Analogue Scale (VAS) for pain in
those patients on post-operative day (POD) one was 1.00 ± 0.49. Those patient suffered significantly less pain than
patients, who underwent conventional single-port VATS in our hospital (n=45, mean VAS on POD 1=1.92 ± 1.01, p
＜0.001).
However, we inevitably encountered some disadvantages for this approach. Apex and posterior mediastnum were
difficult to be reached by conventional VATS instruments. Transient arrhythmia caused by compression of heart by
instruments and endoscope during operation in left pleural cavity occurred occasionally
Herein, we presented our preliminary experience of subxyphoid single-port VATS and the potential advantages
about this approach.
Uniport surgery in thoracic disease using flexible videoscopy
Tzu-Ping Chen, Chi-Hsiao Yeh, Yen-Hun Liu
Department of Thoracic and Cardiovascular Surgery, Chang Gung Memorial Hospital at Keelung`
Background:
Uniport thoracscopic surgery is a very exciting new modality in the field of minimal access surgery which works for
further reducing the scars of traditional three-port thoracopic surgery and towards scarless surgery. By using the rigid
videoscope, single-incision seems to offer an advantage to surgeons with its familiar field of view similar to those
used in conventional thoracotomy. However, the disadvantage is the fencing from individual instruments placed
through the small incision of single-port VATS. rapid progress in instrument design. We describe herein our
technique of performing uniport thoracoscopic surgery using a flexible scope
Materials and Methods:
Between August 2013 and July 2014, 62 uniportal VATS procedures were performed by a single surgeon. Of the 62
uniportal VATS, 6 lobectomies were performed for early stage lung cancer. All procedures were complete with a
10-mm 0-degree rigid endoscope through a plastic wound protector(Alexis®). A 5-mm flexible-tip video endoscope
(HD EndoEYE LTF-VH™; Olympus) was applied during pneumonolysis and mediastinal lymph node dissection.
Vessels were stapled under loverlooking of flexible videoscope, as well as the lobar bronchus.
Results:
No post-operative complication or hospital mortality of uniportal VATS lobectomy was recorded. No patients was
converted to open thoracotomy or created additional skin incisions. Mean operative time of uniportal VATS
lobectomy was 165.6 min (range 110-270) and mean postoperative hospital stay 8.5 days (range 7-12).
Conclusion:
Our experience shows that VATS combines with a flexible scope is feasible in lobectomy, even in some cases of
pleural adhesion. Despite the longer time to perform unport VATS, we consider the combined rigid and flexible
videoscope to achieve better vision and safer maneuver during the operation. We also expect further development of
new ergonomic instruments, robotic arms that open inside the thorax, which may allow the uniportal approach to
become a mainstreams of the major pulmonary resections in most thoracic departments.
POEM in Japan
Hironari Shiwaku1), Haruhiro Inoue2)
Department of Gastroenterological Surgery,
Fukuoka University Faculty of Medicine1)
Digestive Disease Center,
Showa University Koto Toyosu Hospital 2)
【Abstract】
Achalasia, a rare functional motility disorder of the esophagus, is characterized by incomplete lower esophageal
sphincter (LES) relaxation, increased LES tone, and aperistalsis of the esophagus. Clinical symptoms of achalasia
include dysphagia, regurgitation, and chest pain. Peroral endoscopic myotomy (POEM) is a revolutionary therapy for
achalasia that was reported in 2008 by Inoue and colleagues. POEM is less invasive and has a higher curative effect
compared with conventional therapeutic methods; therefore it is expected to become the standard treatment for
achalasia and related disorders worldwide, in the near future. Based on our experience of 850 cases in Japan, we
would like to introduce the technique of POEM procedure and current situation.
POEM in China
Prof. Pinghong Zhou, M.D, Ph.D
Endoscopy Center, Zhongshan Hospital, Fudan University, Shanghai, 200032, China
Peroral endoscopic myotomy (POEM) has been developed as a non-incision, minimally invasive endoscopic
treatment becoming the most effective option for achalasia, maybe the primary and permanent one. This procedure
incorporates concepts of natural orifice transluminal endoscopic surgery (NOTES) and achieves endoscopic
myotomy by using the submucosal tunnel as an operating space. In 2007, Pascricha et al. used this technique firstly
and successfully to perform endoscopic myotomy in a porcine model. Later, Inoue et al. made it successful in human
patients and got a satisfactory outcome. Then, POEM has been developed very quickly and initial published
experience in humans is more than encouraging despite a relatively short follow-up.
In China, the first case of POEM was performed in the Endoscopy Center of Zhongshan Hospital, Shanghai in
August 2010. To date POEM procedures have been performed in over 2000 patients in China, which may be over
half the total cases of the world. China also established its consensus on POEM from academic society in 2012.
Initial experiences from China about management of the complications and POEM for special cases (such as
pediatric patients and patients with sigmoid-type esophagus or recurrent symptoms after Heller myotomy) have been
reported in several international conferences many times. As Chinese doctors become more experienced, they also
make some modifications for achieving long-term symptom remission and reducing the difficulty of POEM. These
modifications include water-jet assisted, posterior wall incision, full-thickness myotomy, and a “push-and-pull”
technique for myotomy, etc. The mean POEM procedure time was just 35 minutes in our unit, and the age of patients
with POEM ranged from 2 to 98 years.
The emerging of POEM marked the rising of a new branch of therapeutic endoscopy—— tunnel endoscopic surgery
(TES), which includes several novel procedures utilizing a submucosal tunnel as an operating space. In 2010, we
innovated a new method by tunneling technique for treating upper gastrointestinal (GI) submucosal tumors (SMTs)
originating from the muscularis propria layer and coined the acronym STER (submucosal tunneling endoscopic
resection). Other applications of tunneling technique include peroral endoscopic submucosal pyloromyotomy for
pyloric stenosis, endoscopic submucosal tunnel dissection for large esophageal neoplastic lesions, etc.
The development of tunnel endoscopic surgery is inspiring for both gastroenterologists and surgeons. The future of
flexible endoscopy is not only operating in the natural orifice but also within and outside the gastrointestinal wall. If
the lumen was historically the first and the peritoneal cavity the second, then the intramural space has come to
represent the “third space.” GI endoscopy has finally entered the (third) space age!
ENB in thoracic disease
上海市肺科医院 汪浩
摘要
电磁导航支气管镜是通过胸部 CT 模拟出虚拟支气管，定位外周病变并在磁场下实时进行导航的前沿技术，
结合肺外周超声能对外周结节进行精确诊断及微创治疗。上海市肺科医院内镜科首次联合使用这两项技术诊
疗肺外周病变，获得了良好的效果。本讲座主要通过介绍电磁导航支气管镜及肺外周超声的原理、设备、操
作方法，复习国外相关文献，总结该院 22 例病例操作详情及结果，展示典型病例，进行分析，让大家对这
一技术有全面的感性认识，也为进一步的推广与研究打下基础。
Transumbilical thoracic sympathectomy: a single center experience of 150 cases with up to 4 years of follow-up.
Weisheng Chen, M.D.
Department of Cardiothoracic Surgery, Fuzhou General Hospital, Fujian Medical University, Fuzhou, China.
Objective: Thoracic sympathectomy is considered as the most effective method to treat palmar hyperhidrosis. Here
we report our experience of transumbilical thoracic sympathectomy with an ultrathin flexible endoscope for palmar
hyperhidrosis in a series of 150 patients with up to 4 years of follow-up.
Methods: A prospective database was used in this retrospective analysis of 150 patients (63 males, 87 females with
mean age of 21.3 years) with palmar hyperhidrosis who were operated by the same surgeon in a single institution
from April 2010 to March 2014. All procedures were performed under general anesthesia involving intubation with a
double-lumen endotracheal tube. Demographic, postoperative, and long term data of patients were recorded and
statistical analyses were performed. All patients were followed-up at least 6 months post procedure through clinic
visits or telephone/e-mail interviews.
Results: The procedure was performed successfully in 148 of the 150 patients. Two patients had to be converted to
conventional thoracoscopic procedure because of severe pleural adhesions. Mean operating time was 43 (ranging
from 39 to 107) min and the mean post-operative stay was one (range 1-4) days. All patients were interviewed 6–48
months after surgery and no diaphragmatic hernia and no Horner’s syndrome was observed. The rate of palmar
hyperhidrosis and axillary hyperhidrosis resolution was 98% and 74%, respectively. Compensatory sweating was
reported in 22.6% of patients. All of the patients were satisfied with the surgical results and the cosmetic outcome of
the incision.
Conclusions: This preliminary human experience suggests that transumbilical thoracic sympathectomy with the
ultrathin flexible endoscope was a safe and efficacious alternative to the conventional approach. This technique
avoided the chronic pain and chest wall paresthesia which associated with the chest incision. In addition, this novel
procedure afforded maximum cosmetic benefits.
Transumbilical thoracic surgery in the lab
Yun-Hen Liu, M.D.
Department of Thoracic Surgery, Chang Gung Memorial Hospital
Since Kallo et al. reported the first transgastric peritoneoscopy in 2004, several studies have shown the safety and
benefits of natural orifice surgery (NOS) in abdominal surgery in human studies. The feasibility of NOS
thoracoscopy has been reported using different natural orifice access (transvesical, transesophageal, transtracheal,
transoral, and transumbilical) in porcine and canine models. However, only a minority of thoracic procedures
(myotomy for achalasia, sympathectomy for palmar hyperhidrosis) are performed using the NOS technique. We
investigated the feasibility of transumbilical thoracoscopy in a canine model. We demonstrated that
pericardial window creation and large lung wedge resection could be performed via a 3 cm vertical transumbilical
incision. More recently, we also found that anatomic lobectomy could be performed with the current approach but
was associated with intraoperative complications. However, we strongly believe that increased familiarity with the
surgical approach and refinement of endoscopic instruments might clarify the role of transumbilical surgery in
thoracic disease.
Database management in Lung Cancer
Sanghoon Jheon, M.D., Ph.D.
Professor and Chairman
Department of Thoracic and Cardiovascular Surgery
Seoul National University College of Medicine, Seoul, Korea
The well-organized database for patients’ clinical information plays important role in medical research. Our
institution has managed the lung cancer patients’ database based on Microsoft Access program since 2003. The
database includes not only clinical information of the lung cancer patients but also information on tissue and blood
samples that collected with informed consent. The database contains information the patients with primary lung
cancer which includes low grade malignancy, recurred lung cancer and primary malignant disease of trachea. The
exclusive manager is in charge of processing data and management of the database to maintain the quality of data.
The basic structure of database consists of 4 categories and is composed of 13 data input sheets per one operation.
The first 3 sheets are for clinical information on patient including previous medical history and data of laboratory,
imaging examinations not only results of staging workup. The next part, made up with 5 input sheets, is designed to
collect staging information of the tumor which includes both clinical and pathological staging data. Staging
information is based upon TNM classification, using independent data columns for each TNM factors. The third part
deals with information on whole treatment that the patient underwent. All information about neoadjuvant treatment,
operation and adjuvant treatment are described in detail. The last part includes follow up data which is obtained
outpatient basis. A nurse practitioner is in charge of update of this part upon each visits of the patient. A protocol
with definition of each item is established to standardize management of the database. Also separately operated
system is set up to manage patients lost to follow up.
The tissue sample for the lung cancer tissue bank is taken at the operation room immediately after excision, prior to
fixation. Both normal parenchymal tissue and tumor tissue are collected and stored in liquid nitrogen tank. Patient’s
arterial blood sample is collected also via arterial line for the intraoperative monitoring and is also stored in the deep
freezer. The record of the tissue and blood samples along with patient’s information is updated by means of both a
printed document and an online-shared electronic document. The management system for tissue bank is prepared to
search information of samples including associated consent forms, and to provide the most up-to-date status for each
samples. Furthermore, information which is managed by the system can be accessed online.
The well-managed database for clinical information and tissue bank are significant background for lung cancer
research and improvement of the treatment for lung cancer.
Database management in esophageal cancer
Yin-Kai Chao MD , PhD
Department of thoracic surgery; Chang Gung memorial hospital, Taoyuan, Taiwan
Carcinoma of the esophagus is a highly malignant cancer and generally carries a poor prognosis. Most patients
presented with advanced disease at initial diagnosis which prohibited any aggressive treatment. 5 yr survival is less
than 25% even after complete surgical removal. In order to improve resectability and reduce distant metastases, the
combination of chemotherapy, radiotherapy and surgery had been introduced since 1995. Recent one meta-analysis
confirmed the benefit of increasing locoregional disease control after such strategy, especially in squamous cell
carcinoma subtype.
However, after the impact of CRT, accurate restaging of patients after resection is important because it provides
prognostic information. Despite the advent of changes in the 7th American Joint Committee on Cancer (AJCC)
staging system with the introduction of new parameters predicting outcomes (e.g., tumor differentiation, histological
subtype, and tumor location), a reliable prognostic framework for ESCC patients undergoing nCRT is still lacking.
Moreover, most data available to date have been obtained from primarily resected patients. In this scenario, the
identification of potential prognostic markers in residual tumors after nCRT has recently gained momentum.
In today's presentation, I will briefly describe CGMH experience in identifying the prognostic markers in
neoadjuvantly treated esophageal cancer patients and our evolution from the "file"-based to "database"-based
approach.
The New Frontiers in Minimally Invasive Thoracic Surgery
Anthony Ping-Chuen Yim, M.D.
Minimally Invasive Thoracic Surgery Centre
The Chinese University of Hong Kong
The past two decades have witnessed the adoption of video assisted thoracic surgery (VATS) to become the new
standard of care in the surgical management of a wide spectrum of thoracic diseases. It also marked the beginning of
technology-dependent operations for thoracic surgeons, and the necessarily close partnership between surgeons and
industry. We are on an innovative technology superhighway and the pace of change is only going to be increasingly
more rapid.
Quest for even less invasive surgical approaches takes two directions. First, there have been refinements of
established VATS techniques which include the uniport approach and designs of miniaturized, procedure-specific
instruments, as well as wireless visualization systems. Second, interests in natural orifice transluminal endoscopic
surgery (NOTES) led to the development of endo-robotic arms, cross-discipline imaging assistance, and
Electromagnetic Navigation Bronchoscopy (ENB) interventional platforms. On the anaesthesia side, it has been
shown that thoracic surgery can be safely performed on sedated patients without intubation and mechanical
ventilation. Thoracic surgery without an incision in an awake patient in an ambulatory setting will one day, no longer
be a fantasy.
BIOGRAPHICAL
Yoshiya Toyoda, M.D., Ph.D.
Vice Chief, Cardiovascular Surgery
Surgical Director, Heart and Lung Transplantation
Director, Mechanical Circulatory Support
Professor, Surgery
Educational Background:
Undergraduate degree, Kobe University, Kobe, Japan, 1986
MD, Kobe University School of Medicine, Kobe, Japan, 1990
Internship, Kobe University Hospital, Kobe, Japan, 1991
Residency, Kobe University Hospital, Kobe, Japan, 1994
Fellowship, Cardiac Surgery, Massachusetts General Hospital, Boston, MA
Fellowship, Cardiopulmonary Transplant and Assist Device, University of Pittsburgh Medical Center
Fellowship, Cardiac Surgery, Kobe Children's Hospital, Kobe, Japan
Clinical Interests:
Surgical treatment for end-stage cardiopulmonary diseases including heart and lung transplantation
Mechanical circulatory support and artificial lung
Major cardiac surgery such as repair of aortic aneurysm and dissection, valve repair/replacement
Coronary artery bypass
Adult congenital heart surgery
Board certification(s):
Thoracic and Cardiac Surgery
Surgery
PROFESSIONAL AFFILIATIONS:
American Association for Thoracic Surgery
Society of Thoracic Surgeons
International Society of Heart and Lung Transplantation
Research Interests:
Myocardial protection/preservation
Pulmonary protection/preservation
Cardiac artery function, Xenotransplantation
王 俊 主任醫師 教授 博士生導師
工作單位:北京大學人民醫院胸外科，胸部微創中心，100044
職稱：主任醫師，教授，博士研究生導師
職務：北京大學人民醫院胸外科，主任
北京大學人民醫院胸部微創中心，主任
北京市海澱醫院胸外科，主任（兼）
名譽職稱：廣東佛山市第一人民醫院，技術指導，客座教授
陝西省人民醫院，客座教授
河北醫科大學第一醫院，名譽教授
專業特長：普通胸外科；胸部腫瘤；胸腔鏡外科；肺氣腫外科，縱隔鏡肺癌外科
重要成就： 創立了我國一個新學科-中國電視胸腔鏡外科和胸部微創外科
建立了我國術前定量預測術後肺功能的核素檢查方法
在國際上首先證明 DLco 與併發證、死亡率和長期生存率關係
開創了我國的肺氣腫外科學
在中國首先開展電視縱隔鏡手術
在中國積極倡導並首先開展肺癌外科規範化治療
教育情況:
1978-1980
1980-1985
河南省淮濱縣高級中學, 畢業
河南醫科大學醫學系, 畢業 ,學士學位
1985-1989
1995.5-8
北京醫科大學研究生院, 畢業, 碩士學位
國際抗癌聯盟（UICC），ICRETT Fellow
1997-1998
工作情況:
1985-1990
1990-1995
1995-2000
1996-2000
1999-2000
2000-2002
2000-目前
2001-目前
美國胸外科學會(AATS)，Graham Fellow
北京醫科大學第一醫院, 住院醫師和總住院醫師
北京醫科大學第一醫院, 主治醫師
北京醫科大學第一醫院, 副主任醫師
北京醫科大學第一醫院, 副教授
北京醫科大學第一醫院胸外科, 副主任
北京大學人民醫院胸外科，主任醫師，教授，副主任
北京大學人民醫院胸部微創中心，主任醫師，教授，主任
北京大學人民醫院胸部微創中心，胸外科，博士生導師
2002-目前 北京大學人民醫院胸外科，胸部微創中心，主任
2003-目前 北京市海澱醫院胸外科，主任（兼）
Autobiography
王俊教授 1995 年畢業于河南醫科大學並在北京醫科大學完成研究生學業，後由美國胸外科學會資助在美
國 8 所著名醫院胸外科訪問學習。現任教授、博士生導師、北京大學人民醫院胸外科主任、胸部微創中心主
任、北京海澱醫院胸外科主任。王俊教授是我國胸部微創外科的開拓者，開拓了包括電視胸腔鏡、電視縱隔
鏡、電視硬氣管食管鏡在國內的臨床應用，並已組織舉辦了九屆胸腔鏡手術學習班，培養了國內 70%的胸腔
鏡外科醫師。除微創外科，王俊教授還建立了我國術前定量預測術後肺功能的核素檢查方法；在國際上首先
證明 DLco 與併發證、死亡率和長期生存率關係，並且在肺癌新輔助化療和分子水平胸部惡性腫瘤早期診斷
方面進行了大量研究，完成國家及省部級課題 6 項，發表論文 100 余篇，主編專著 5 部。
王俊教授曾獲國際抗癌聯盟，ICRETT Fellow 和美國胸外科學會，Graham Fellow。現為中華胸心血管外
科學會胸腔鏡外科學組組長、國際食管疾病學會(ISDE)亞洲主席、國際抗癌中華醫學會北京分會胸外科專業
委員會常委、中華醫學會胸心血管外科學分會全國委員、中華全國青年聯合會第九屆委員會全國委員、亞太
地區胸腔鏡外科學會執行委員、聯盟(UICC)會員協會會員、美國胸外科學會(AATS)執行會員、北京醫療事故
鑒定委員會委員。王俊教授還擔任《中華胸心血管外科雜誌》編委，《中華外科雜誌》編委，《循證醫學》
編委，《中國肺癌雜誌》常務編委，《中國微創外科雜誌》常務編委，《中國胸心血管外科臨床雜誌》編委，
《食管外科》編委，《腹腔鏡外科雜誌》編委，《淮海醫藥》編委等。
CURRICULUM VITAE
Department of Gastrointestinal Oncology
Esophageal Surgical Division
National Cancer Center Hospital EAST
NAME
Hiroyuki DAIKO
PERSONAL DATA
Place of Birth; Japan
Citizenship; Japanese
EDUCATION
2007 Ph.D. Tokyo Woman’s Medical University
1994 M.D.
Tokai University School of Medicine
PERSONAL EXPERIENCE
2013
Director of Esophageal Surgical Division
Department of Gastrointestinal Oncology
Esophageal Surgical Division
2004
2002
2001
1998
1995
1994
National Cancer Center Hospital EAST
Staff Surgeon of Esophageal Surgical Division
Department of Gastrointestinal Oncology
Esophageal Surgical Division
National Cancer Center Hospital EAST
Research Resident
Genetics Division
National Cancer Center Hospital Research Institute
Clinical Senior Resident
Department Surgery
Esophageal Surgical Division
National Cancer Center Hospital Central
Clinical Junior Resident
Department Surgery
National Cancer Center Hospital Central
Clinical Resident
Department Surgery
Seirei Hamamatsu General Hospital
Clinical Resident
Department Surgery II
Tokyo Woman’s Medical University
CURRICULUM VITAE
Name: Liu, Hui-Ping
劉 會 平
Employment Record:
May 1987 ~ June 1990
July 1990 ~ June 1992
July 1992 ~ July 2009
Aug 1993 ~ July 2000
July 1997 ~ June 2003
R1~ R3, Dept of Surgery, Chang Gung Memorial Hospital, Taipei
Fellow, Dept of Thoracic & Cardiovascular Surgery, CGMH, Taipei
Attending Staff, Dept of Thoracic & Cardiovascular Surgery, CGMH
Lecturer of Thoracic & Cardiovascular Surgery, Chang Gung University
Associate Professor of Thoracic & Cardiovascular Surgery,
Chang Gung Memorial Hospital
July 1999 ~ June 2006 Chief, Division of Thoracic Surgery,
Chang Gung Memorial Hospital, Linkou Medical Center
Aug 2000 ~ July 2005 Associate Professor of Surgery, Chang Gung University
July 2003 ~ July 2009 Professor of Thoracic & Cardiovascular Surgery,
Chang Gung Memorial Hospital
Aug 2005 ~ July 2009 Professor of Surgery, Chang Gung University
Aug 2006 ~ July 2009 Vice-superintendent
Chang Gung Memorial Hospital, Keelung
July 2009 ~ 2011
Superintendent, BenQ Hospital, Nanjing, China
Nov 2011 ~
Superintendent, New Journey Hospital, Beijing, China
Professional Affiliations:
1. Formosan Medical Association
2. The Surgical Association of the Republic of China (1991)
3. Taiwan Society of Cardiology (1992)
4. Association of Thoracic & Cardiovascular Surgery, Republic of China (1992)
5. Surgical Society of Gastroenterology, Republic of China (1992)
6. International Society of Cardiothoracic Surgeons (ISCTS)(1993)
7. Taiwan Society of Pulmonary and Critical Care Medicine (1993)
8. Chinese Association for Endoscopic Surgery (1993)
9. Collegium Internationale Chirurgiae Digestivae (CICD)(1993)
10. American College of Chest Physicians (FCCP) (1993)
11. Endoscopic and Laparoscopic Surgeons of Asia (ELSA) (1994)
12. World Association for Bronchology (1994)
13. American Association for Bronchology (1994)
14. European Association for Endoscopic Surgery (EAES) (1994)
15. International Society for Disease of the Esophagus (ISDE)(1997)
16. Society of Thoracic Surgery (STS) USA (1998)
17. American College of Surgery (FACS) (1998)
18. Asian Pacific Society of Respirology (APSR) (1998)
19. Asian Society for Cardiovascular Surgery (1998)
20. International Association for the Study of Lung Cancer (IASLC) (1999)
21. The International Pediatric Endosurgery Group (IPEG)(1999)
Research Interest:
1. Minimal access thoracic surgery
2. Lung Transplantation
3. Thoracoscopic Surgery (Video-assisted thoracic surgery)
4. Esophageal Surgery
5. Traditional Chinese Medicine (CAM)
Dae Joon Kim, MD
1. Affiliation
- Assistant professor, Department of Thoracic & Cardiovascular Surgery, Yonsei University College of Medicine,
Seoul, Korea
- Head, Lung Cancer Center, Yonsei Cancer Hospital, Seoul, Korea
- Vice director, Emergency Center, Severance hospital, Seoul, Korea
2. Education & Training
- Graduated Yonsei University College of Medicine in 1993
- Completed cardiothoracic residency at Severance hospital in 1998
- Completed master in medical science in 2004
3. Professional appointment
- 2002 / 2003 : clinical fellow, Severance hospital
- 2004 / 2005 : Instructor, Department of Thoracic & Cardiovascular Surgery, Yonsei University
- 2008 / 2010 : Professor of Surgery, King Saud University, Riyadh, Kingdom of Saudi Arabia
4. Academic activities
- Head, Educational committee, Korean Association of Thoracic Surgical Oncology
- Executive director, Korea Association of Broncho-esophagology
- Member, Educational committee, Korean Association of Thoracic & Cardiovascular Surgery
- Member, International relations committee, Korean Association of Study for Lung Cancer
5. Main interests
- Robot-assisted thoracoscopic surgery for esophageal cancer
- Lymph node navigation using the robotic system
- Management of multiple GGOs in lung cancer
- VATS segmentectomy
CURRICULUM VITAE
Jang-Ming Lee, MD., PhD.
Dept. of Surgery, National Taiwan University Hospital
No.7, Chung Shan S. Rd., Taipei 100, Taiwan, ROC
EDUCATION
PhD.
1996-2001
Graduate Institute of Clinical Medicine, National Taiwan University, Taipei,
Taiwan, ROC
M.D. 1982-1989
College of Medicine, National Taiwan University, Taipei, Taiwan, ROC
TEACHING EXPERIENCE
Professor
2014-present
Clinical professor
2012-2013
Clinical associate professor
2006-2011
College of Medicine, National Taiwan University, Taipei, Taiwan, ROC
Clinical assistant professor
2002-2005
College of Medicine, National Taiwan University, Taipei, Taiwan, ROC
PROFESSIONAL EXPERIENCE
Chief, Division of Thoracic Surgery
2011-present
Dept. of Surgery, National Taiwan University Hospital, Taipei, Taiwan, ROC
Visiting Staff
1996-present
Dept. of Surgery, National Taiwan University Hospital, Taipei, Taiwan, ROC
Research Fellow
1999-2000
Dept. of Surgery, Beth Israel, Deaconess Medical Center Harvard Medical School, Boston MA, USA
Resident
1991-1996
Dept. of Surgery, National Taiwan University Hospital, Taipei, Taiwan, ROC
Secretary General
Taiwan Association of Thoracic ＆ Cardiovascular Surgery
2014-present
Asia Thoracoscopic Surgery Education Program
2014-present
Committee member
Taiwan Association of Thoracic ＆ Cardiovascular Surgery
2006-present
Association of International Chinese Thoracic
＆Cardiovascular Surgery
Asia Thoracoscopic Surgery Education Program
Reviewer
International Journal of Cancer
Taiwan Surgical Association
Formosan Medical Association
2007-present
2014-present
2001-present
2001-present
2003-present
Cancer Letters
Carcinogenesis
Asian Journal of Surgery
Editor
Asian Journal of Surgery
American Journal of cancer review
Hindawi Journals
Translational Cancer Research
2005-present
2006-present
2010-present
2014-present
2013-present
2014-present
2011-present
HONORS AND AWARDS
 Best Research Paper-Type B, National Science Council, Taiwan, ROC (2000)


Scientific Abstract Award, 12th World Congress of the International Society for Diseases of the Esophagus,
Kagoshima, Japan (2010)
Best Teaching Award of attending physicians in NTUH, NTUMC North American Alumni Foundation (2014)
PATENT
US 6,639,122 B1 (2003-2020)
Title: Transgenic swine having HLA-D gene, swine cells thereof and xenografts there from
US 20110091871 A1 (2009~2029)
Title: Biomarkers for predicting response of esophageal cancer patient to chemoradiotherapy
Curriculum Vitae
Name: Chih-Cheng Hsieh
Current title: Attending Surgeon of Thoracic Surgery
Division of Thoracic Surgery, Department of Surgery, Taipei-Veterans General Hospital
Education:
1985-1992 School of Medicine, National Yang-Ming University, Taipei, MD degree
2005-2007 Institute of Hospital and Health Case Administration, National Yang-Ming University, Taipei, Master
degree
2009-Present Institute of Clinical Medicine, National Yang-Ming University, Taipei
Professional career:
1990-1992 Taipei-Veterans General Hospital Taipei, Internship
1992-1994 Nan-Tze Veterans Hospital, Kaohsiung, Resident
1994-1998 Taipei-Veterans General Hospital Taipei, Resident
1998-1999 Taipei-Veterans General Hospital Taipei, Chief Resident
1999-2000 Taipei-Veterans General Hospital Taipei, Clinical Fellow
2000-2011 National Yang-Ming University, Taipei, Taiwan, Lecturer of Surgery
2001-Present Taipei-Veterans General Hospital Taipei, Attending Surgeon
2003-2004 Southern California University, Los Angeles, CA, USA, Research Fellow
2008-2011 Secretary in General, Taiwan Association of Thoracic and Cardiovascular Surgery
2011-Present National Yang-Ming University, Taipei, Taiwan, Assistant Professor
Board Certification and Membership:
1992 Doctor of Medicine, Department of Health, Taiwan
1998 Board of General Surgery, Department of Health, Taiwan
1999 Board of Taiwan Association of Thoracic and Cardiovascular Surgery
1999 Board of Taiwan Society of Pulmonary and Critical Care Medicine
2000 Board of Taiwan Surgical Society of Gastroenterology
2000 Board of Taiwan Association for Surgery of Trauma
2000 Board of Taiwan Association for Endoscopic Surgery
2008
Member of The Society for Surgery of the Alimentary Tract (SSAT)
Curriculum Vitae
Name
YingChieh Su, 蘇英傑
Current
position
Attending physician, Department of thoracic surgery, Chimei medical center
財團法人奇美醫學中心胸腔外科主治醫師
Attending physician, Department of medical education, Chimei medical center
財團法人奇美醫學中心教學主治醫師
Consultant, HIWIN technology corp.
上銀科技研發顧問
Academic
interests
Esophageal cancer
Lung cancer
Videothoracoscopic surgery (VATS, MIS, MIE)
da Vinci robotic surgery (RATS, RAMIE)
Medical robot development
Hepatic(Renal) hydrothorax
Medical photonic system
Education
Medical
training
Medical
certification
Department of medicine, Kaohsiung medical university,
Kaohsiung, Taiwan
高雄醫學大學醫學系畢業
1996-2003, MD
Department of photonic system, National Chiao Tung
university, Tainan, Taiwan
交通大學光電系統研究所博士班就學中
2012-now, PhD
Resident and chief resident, department of thoracic
surgery, Chimei medical center, Tainan, Taiwan
2003-2008
Mayo clinic visiting staff
2011/8-2012/1
Memorial Sloan-Kettering cancer center (MSKCC)
visiting staff
2012/1-2012/2
Surgeon specialist, R.O.C.
中華民國外科醫學會專科醫師
Pulmonary and Cardiovascular Surgeon specialist, R.O.C.
中華民國胸腔暨心臟血管外科醫學會專科醫師
Trauma specialist, R.O.C.
台灣外傷醫學會專科醫師
Surgical intensive care specialist, R.O.C.
台灣外科醫學會外科重症加護專科醫師
教學資歷
奇美醫學中心臨床教師
台灣醫學教育學會一般醫學師資
奇美醫學中心教學主治醫師
教學榮譽
奇美醫院 99 年度優良教師第二名
奇美醫院 100 年度優良教師第三名
奇美醫院 101 年度傑出教師
奇美醫院 103 年度跨職類教學特殊貢獻獎
CURRICULUM VITAE
Name: Hsieh, Ming-Ju
謝明儒
Education:
1986~1990 Medical College, National Taiwan University, Taipei, Taiwan, R.O.C.
1990~1995 Kaohsiung Medical College, Kaohsiung, Taiwan, R.O.C.
Employment Record:
July 1994~June 1995 Internship, Chang Gung Memorial Hospital
Aug 1995~July 1998 R1, R2 & R3, Div of General Surgery, Chang Gung Memorial Hospital
Aug 1998~July 2000 Fellow, Div of Thoracic & Cardiovascular Surgery, CGMH
Aug 2000~
Attending Staff, Div of Thoracic Surgery, CGMH
Dec 2002~Aug 2004 Chief, Div of Thoracic Surgery, CGMH at ChaiYi
July 2009~
Assistant Professor, Div of Thoracic & Cardiovascular Surgery, CGMH
Aug 2010~
Assistant Professor of Surgery, Chang Gung University
Feb. 2011~
Physician Educator, Chang Gung Memorial Hospital
Professional Affiliations:
1. Taiwan Surgical Association (1999)
2. Taiwan Association of Thoracic & Cardiovascular Surgery
3. Taiwan Society of Pulmonary and Critical Care Medicine
4. Chinese Association for Endoscopic Surgery
5. Taiwan Lung Cancer Society
6. American College of Chest Physicians (FCCP)
7. The International Association for the Study of Lung Cancer(IASLC)
8. Taiwan Association of Medical Education
Research Interest: Cardiovascular and Thoracic Surgery, Medical Education
Curriculum Vitae
Name: Cheng-Yen Chuang, MD.
Current Title: Attending Surgeon of Thoracic Surgery
Hobbies and Interests:
 Bicycle
 Badminton
Address:
 Office: Division of Thoracic Surgery, Surgical department, Taichung Veterans
General Hospital
#1650, Sect.4, Taiwan Boulevard, Taichung, Taiwan
Education and Training:
 1985-1992 Taipei Medical College, MD. Degree
 1992-1994 Military Service
 1994-1998 Taichung Veterans General Hospital, Resident
 1998-1999 Taichung Veterans General Hospital, Chief Resident
 2012 Chung-Shan Medical University, MD. PhD Degree
Career to Date:
 1999-2004 Attending Surgeon of Thoracic Surgery (Taichung Veterans General Hospital)
 2004-2007 Chief of Thoracic Surgery (Chung-Hwa Show Chwan Memorial Hospital)
 2007-present Attending Surgeon of Thoracic Surgery (Taichung Veterans General Hospital)
Memberships of Associations and Institutes:
 1998, Board of General Surgery, Taiwan
 1999, Board of Taiwan Society of Pulmonary and Critical Care Medicine
 1999, Borad of Association of Thoracic and Cardiovascular Surgery
 2000, Board of Digestive Endoscopic Society of Taiwan
 2004, Board of Taiwan Society of Critical Care Medicine
Diego Gonzalez Rivas, M.D, FETCS
Coruña University Hospital
Xubia 84
Coruña 15008
Spain
Role:
Surgeon
Subspecialty(ies)
General Thoracic Surgery
Background
Dr. Diego Gonzalez Rivas is a graduate of Santiago de Compostela University and the College of Physicians &
Surgeons of Coruña University (MD). He received training in General Surgery, Thoracic Surgery, and lung
transplantation at Coruña University Hospital.
After completing a year working in Santiago University Hospital he joined the faculty at Coruña Hospital and is
currently Thoracic Surgeon in Coruña University center and an active member of lung transplantation program. He is
the head of minimally invasive thoracic surgery Unit working at Coruña hospital, USP institution, San Rafael
hospital and Modelo medical center.
Dr Gonzalez Rivas serves on several editorial boards and is active member organizing the annual meeting of Spanish
society of thoracic surgery (SECT) and collaborate with educational activities of European Society (ESTS). He is a
board European certified surgeon since 2010 (FECTS). He is specially dedicated to minimally invasive thoracic
surgery (VATS). He was pioneer surgeon in the world performing uniportal VATS lobectomies and he has published
several papers describing this procedure and the results in the most important medical journals.
Interests
Uniportal VATS lobectomy
Minimally invasive thoracic surgery
Single-port VATS sleeve resection
Advanced lung cancer surgery
Robotic surgery
Lung Transplantation
Video edition
Surfing
Curriculum Vitae
NAME:
Jin-Shing Chen, M.D. PhD
CURRENT
APPOINTMENT:
Professor, Department of Surgery, National Taiwan
University School of Medicine
Director, Department of Traumatology, National
Taiwan University Hospital
Chief, Division of Experimental Surgery, National
Taiwan University Hospital
Attending Surgeon, Division of Thoracic Surgery,
National Taiwan University Hospital
EDUCATION:
1986-199 M.D., National Taiwan University, Taiwan.
3
1999-2004
PhD of Institute of Clinical Medicine
National Taiwan University, School of Medicine
POSTDOCTORAL TRAINING
1994-1999 Residency
National Taiwan University Hospital, Taipei, Taiwan
Resident in Surgery, 1994-1997
Chief Resident in Surgery, 1997-1998
1999-2000 Research follow
Division of Thoracic Surgery, Department of Surgery, National
Taiwan University Hospital, Taipei, Taiwan
2002-2003 Visiting scientist
Department of Molecular and Cellular Oncology,
MD Anderson Cancer Center, University of Texas, TX, USA
EMPLOYMENT:
2000-present Attending Surgeon
Division of Thoracic Surgery, Department of Surgery
National Taiwan University Hospital
2001-2004 Instructor, Department of Surgery, National Taiwan University
School of Medicine
2004-2009 Assistant Professor of Surgery, National Taiwan University School of
Medicine
2009-2013 Associate Professor, Department of Surgery, National Taiwan
University School of Medicine
2009-2011 Chief, Department of Surgery, National Taiwan University Hospital
Yun-Lin Branch
2009-2011 Chief, Center of Oncology, National Taiwan University Hospital
Yun-Lin Branch
2012-present- Deputy Editor in Chief, Journal of Thoracic Disease (SCIE)
Editor, Journal of Formosan Medical Association (SCI)
Editor, Scientific reports (SCI)
Membership
Taiwan Surgical Association, member
Taiwan Association of Thoracic and Cardiovascular Surgery, member
Taiwan Society of Pulmonary and Critical Care Medicine, member
Awards and Hono
r
2006: Best Attending Physician, National Taiwan University Hospital
2007: Best Teaching Award, National Taiwan University Hospital
2008: Best Clinical Teacher, National Taiwan University Hospital
2009: Certification of Symbol of National Quality, Center of
Oncology, NTUH Yin-Lin Branch
2009: Teaching award, National Taiwan university
2010: Teaching award, National Taiwan university
2011: Teaching award, National Taiwan university
2012: Excellent Research Award, National Taiwan university Hospital
2013: Excellent Research Award, National Taiwan university Hospital
2014: Teaching award, National Taiwan university
Areas of Research Interest:
1. Non-intubated thoracoscopic surgery
2. Innovative treatment for lung cancer
3. Treatment for primary spontaneous pneumothorax
4. Clinical trials for lung cancer and pneumothorax
Liu Chia-Chuan, M.D
Specialty: Minimally invasive thoracic surgery for lung and esophageal cancer
School :
China Medical
University 1992
Residency: Taipei Veterans General Hospital
Fellowship: Thoracic Surgery, Taipei Veterans General Hospital
Observer in Duke University Hospital 2007/7-2007/9
OFFICE:
Koo Foundation Sun Yat-Sen Cancer Center.
125 Lih-Der Road, Pei-Tou District, Taipei, Taiwan. (Zip code 11259)
-Biography
Dr. Chia-Chuan Liu graduated from China Medical University in 1992, and completed his residency and fellowship
training in the Veteran General Hospital-Taipei in 2000. He now heads the thoracic surgery division in SYSCC, and has
chaired the minimally invasive committee since 2008.
His clinical interest is multimodality and minimally invasive surgery for lung and esophageal cancer. He initiated
the VATS forum in Taiwan early in 2005, doing live demonstration surgery for VATS lobectomy and minimally invasive
esophagectomy for both Taiwan and foreign chest surgeons, collaborated with other leaders to set up animal lab worshop
in Taiwan, and he is also now engaged in establishing the “Taiwan Esophageal Cancer Study Group” based on a
nation-wide database -Taiwan Cancer Registry.
Membership
in Professional Societies
Member, Taiwan Joint Cancer Association
Member, Taiwan Surgical Association
Member, Taiwan Society of Thoracic & Cardiovascular Surgery
Member, Taiwan Society of Pulmonary and Critical Care Medicine
Member, Taiwan Surgical Society of Gastroenterology
Member, The Society of Ultrasound in Medicine, R.O.C.
Academic Appointment
Lecturer, Department of Surgery, National Defense Medical Center
Clinical Assistant Professor of Surgery, National Yang-Ming University College of Medicine
Clinical Interests:
Thoracic minimally invasive surgery (Video Assisted Thoracic Surgery)
Single port surgery for primary lung cancer
Minimally invaive surgery for esophageal cancer and cancer of gastric cardia
Surgery for mediastinal tumor
Fellowship training program for thoracic minimally invasive surgery
1.
Research Interests:
Clinical research for lung cancer
Clinical research for esophageal cancer
Affiliations/ Certifications:
1999
Board of Surgery
1999
Board of Thoracic Surgery
1999
Board of Pulmonary and Critical Care Medicine
Academic / professional Titles:
Chair of Minimally Invasive Surgery Committee
Vice leader of Lung and Esophageal Cancer Functional Group, SYSCC.
Member of Intensive Care Unit Committee, SYSCC
Curriculum Vitae
一、
個人背景
姓名：林洧呈 Wei-Cheng Lin
二、
學、經歷
臺北市立萬芳醫院
胸腔外科
代主任/主治醫師
2012年09月-迄今
新光醫院
胸腔外科
兼任主治醫師
2012年11月-迄今
新光醫院
胸腔外科
主治醫師
2007年07月-2012年08月
新光醫院
外傷科
兼任主治醫師
2010年02月-2012年08月
臺大醫院
胸腔外科
總住院醫師
2005年07月-2007年06月
臺大醫院
外科部
住院醫師
2002年07月-2005年06月
國立台灣大學
電機資訊學院
生醫電子與資訊學研
2008年09月-迄今
究所博士班
國立台灣大學
三、
醫學院
醫學系
1994年09月-2001年06月
相關證書
醫師證書
外科專科醫師證書
台灣胸腔及心臟血管外科醫學會專科醫師證書
台灣胸腔暨重症專科醫師證書
台灣外科重症加護專科醫師證書
四、研究成果目錄
Wei-Cheng Lina, Yung-Chie Leea, Jin-Shing Chena, Wen-Je Koa, Shuenn-Wen Kuoa,
2007
Hsao-Hsun Hsua. Add-on sildenafil therapy for chronic thromboembolic pulmonary
hypertension. Respiratory Medicine Extra.Volume 3, Issue 3, 2007, 130–133
2007
Lin WC, Tseng YT, Chang YL, Lee YC. Pulmonary tumour with high carcinoembryonic
antigen titre caused by chronic propolis aspiration. Eur Respir J. 2007 Dec;30(6):1227-30.
Intramuscular Lipoma Arising in the Intercostal Muscle-A Case Report
2008
肋間肌肉肌內脂肪瘤－病例報告
林洧呈(Wei-Cheng Lin);張逸良(Yih-Leong Chang);李元麒(Yung-Chie Lee)
胸腔醫學 Thoracic Medicine Vol.23 No.1 (2008/02) 31-35
CURRICULUM VITAE
Name: Chen, Tzu-Ping
Education:
1989~1996
陳 子 平
China Medical College, Taichung, Taiwan
Employment Record:
July 1998 ~ June 2001 R1~ R3, Dept of Surgery, Chang Gung Memorial Hospital, Taipei
July 2001 ~ June 2003 Fellowship, Div of Thoracic & Cardiovascular Surgery, CGMH, Taipei
July 2003 ~ Sep 2003 Attending physician, Div of Thoracic & Cardiovascular Surgery, CGMH, Taipei
Oct 2003 ~ June 2004 Attending physician, Div of Thoracic & Cardiovascular Surgery, CGMH, Jyayi
July 2004 ~ Attending physician, Div of Thoracic & Cardiovascular Surgery, CGMH, Keelung
Research Interest:
1. Minimal access thoracic surgery
2. Thoracoscopic Surgery (Video-assisted thoracic surgery)
3. Mininvasive Esophageal Surgery
CURRICULUM
VITAE
PERSONAL INFORMATION
Name : Hironari Shiwaku
Present Affliliation : Department of Gastroenterological Surgery,
Fukuoka University, Faculty of Medicine,
Nanakuma 7-45-1, Jonan-ku, Fukuoka, 814-0180, Japan
WORK EXPERIENCE
2003Resident, Department of Gastroenterological Surgery, Fukuoka University, Faculty of Medicine, Fukuoka, Japan
2004Resident, Department of Surgery, Kitakyushu Municipal medical center, Fukuoka, Japan
2005Surgical stuff, Yamamoto Memorial Hospital, Saga, Japan
2006Senior Resident, Kitakyushu Municipal medical center, Fukuoka, Japan
2007Research Associate, Department of Gastroenterological Surgery, Fukuoka University, Faculty of Medicine,
Fukuoka, Japan
2008-2009
Assistant Professor, Digestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama,
Japan
2010Research Associate, Department of Gastroenterological Surgery, Fukuoka University, Faculty of Medicine,
Fukuoka, Japan
EDUCATION AND DEGREE
March 2003
Graduated from Fukuoka university, School of medicine
Fukuoka, Japan
April 2003
Success in the National Examination for Medical Practitioner
( The registration number: 436717)
Awarded the degree of Medical Sciences (M.D.)
MEMBERSHIP
Japan Surgical Society
Board Certified Surgeon
Japan Gastroenterological Endoscopy Society
Board Certified Member, Councilor
Councilor
Japanese gastrointestinal association
Board Certified Member
American Society for Gastrointestinal Endoscopy (ASGE)
International membership
PRIZE
✤Ito Prize of Japan society for endoscopic surgery (2011)
‘Clinical experience of full thickness resection of early gastric cancer with severe scar : CLEAN-NET
(Combination of Laparoscopic and Endoscopic Approaches to Neoplasia with Non Exposure Technique)’
✤1st.prize of International Symposium on Complications in GI Endoscopy
(Hannover, 2009)
‘Cases of perforation during and after ESD procedure’
Pinghong ZHOU, MD, PhD
Dr. Pinghong Zhou is currently a specialist in therapeutic endoscopy, as well as a general surgeon of Zhongshan
Hospital, Fudan University, Shanghai, China.
Dr. Zhou graduated from Shanghai Medical University in 1992, and obtained his doctorate degree (Doctor of
Surgery) from Fudan University in 2003. Having completed his basic surgical training in the department of general
surgery of Zhongshan Hospital from 1992 to 1998, he started his training in digestive endoscopy as a senior resident
in 1999. He also received the most comprehensive training in various areas of advanced endoscopy, such as EUS
under the mentorship of Kenjiro Yasuda in Kyoto Second Red Cross Hospital of Japan in 2000, ESD under Hiroyuki
Ono in Shizuoka Cancer Center of Japan in 2006, ERCP under Peter B Cotton in the Medical University of South
Carolina, USA in 2008.
His main medical work focuses on endoscopic diagnosis and treatment of gastrointestinal tumor. He is one of ESD
pioneers in China and has gained much experience in EMR, EPMR and ESD. Recently he is very interested in
endoscopic resection of submucosal tumor (SMT) and tunnel endoscopic surgery, such as submucosal tunnel
endoscopic resection (STER), peroral endoscopic myotomy (POEM) of esophageal achalasia.
He has already edited 3 books on ESD and endoscopic resection and published over 100 papers in Chinese journals
and 50 papers in international peer-reviewed journals such as Endoscopy, Gastrointestinal Endoscopy and Surgical
Endoscopy. Also he has chaired 1st to 7th Sino-Japan Summit Forum on ESD and more than 30 ESD and POEM
training courses in China, giving presentations and live demonstration in more than 30 countries.
上海市肺科医院 汪浩主任医师 工作经历
90 年复旦大学医学院毕业后即在上海市肺科医院胸外科工作至今
1997 年 10 月-12 月在日本大阪府羽曳野病院研修
2008 年获得苏州大学硕士学位
2008 年内窥镜室主任，主持医院内窥镜室工作
曾获得上海市科技进步奖二等奖 2 次，教育部科技进步奖二等奖 1 次，中华科技进步奖二等奖 1 次
主要学术任职
任上海市医学会中西医胸外科分会委员
CURRICULUM VITAE
Name:
Office Address:
Education:
2004-2006
1996-1999
1991-1996
Weisheng Chen
Cardiothoracic Surgery Department
Fuzhou General Hospital, Fuzhou, China
------- Fujian Medical University, PhD
------- The First Military Medical University, Master of Surgery
------- The First Military Medical University, Medical Bachelor, MD
Professional Experience:

1999 – 2000

2000 – 2001

2001 – 2002

2002 – 2004

2003 – 2006

2006 – 2007

2008–2009

2009-pres
Intern and Junior Resident in General Surgery
Fuzhou General Hospital (a Teaching Affiliate Hospital of
Fujian Medical University)
Senior and Chief Resident in General Surgery
Fuzhou General Hospital
Critical Care Medicine Fellowship
Fuzhou General Hospital
Clinical Fellowship Cardiothoracic Surgery
Fuzhou General Hospital
Resident and Chief Resident in Cardiothoracic Surgery
Fuzhou General Hospital
Clinical Fellowship VATS
Minimally Invasive Surgery Center, Guanzhou
Medical School of Guanzhou Affiliated Hospitals
Clinical research fellow
Department of Surgery, Keck Medical School, USC
Assistant Professor of Thoracic Surgery.
Department of General Thoracic Surgery, Fuzhou General Hospital
Research/Funding Information:

2004-2006

2006-Present
Computer-Aided Surgery and VATS
Supported by the Natural Science Foundation of Fujian Province of China
Simplified implantation procedure of the stentless aortic
valve (sutureless xenografts aortic valves)
Supported by the Natural Science Foundation of Fujian
Province of China
Board Certification And Licensure:
Chinese Surgeon, 2002
Chinese Society of Cardiac and Thoracic Surgeons 2005
CURRICULUM VITAE
Name: Liu, Yun-Hen 劉永恆
Office Address: Thoracic & Cardiovascular Surgery, Chang Gung Memorial Hospital
5, Fu-Hsing Street, Kuei-Shan Hsiang, Taoyuan Hsien, Taiwan 333
Education:
1986~1993 Taipei Medical College, Taipei, Taiwan
Employment Record:
Jul 1994 ~ Jun 1997
Jul 1997 ~ Jun 1999
R1~R3, Dept of Surgery, Chang Gung Memorial Hospital
Fellow, Div of Thoracic & Cardiovascular Surgery, CGMH
Jul 1999 till now
Attending Staff, Section of Thoracic Surgery, CGMH
Sep 2000 ~ May 2001 Clinical Fellow, Division of Cardiothoracic Surgery, University of Washington, Seattle,
Washington, USA
May 2001~ June 2001 Clinical Fellow, Division of General Thoracic Surgery, Massachusetts General Hospital,
Boston, Massachusetts, USA
Jun 2001~ Aug 2001 Clinical Fellow, Department of Cardiothoracic Surgery, Washington University School of
Medicine, Barnes-Jewish Hospital, St. Louis, USA
Jul 2004 ~ Jun 2010
Assistant Professor, Div of Thoracic & Cardiovascular Surgery, CGMH
Aug 2005 ~ Jul 2011 Assistant Professor of Surgery, Chang Gung University
Jul 2010 ~ present
Associate Professor, Div of Thoracic & Cardiovascular Surgery, CGMH
Aug 2011 ~ 2014
Associate Professor of Surgery, Chang Gung University
Aug 2014 ~ present
Professor of Surgery, Chang Gung Memorial Hospital
Board Certification:
1. The Surgical Association of the Republic of China
2. Association of Thoracic & Cardiovascular Surgery, Republic of China
3. Chinese Association for Endoscopic Surgery
4. Taiwan Society for Vascular Surgery
Professional Affiliations:
1. Formosan Medical Association
2. The Surgical Association of the Republic of China
3. Association of Thoracic & Cardiovascular Surgery, Republic of China
4. Taiwan Society of Pulmonary Critical Care Medicine
5. Chinese Association for Endoscopic Surgery
6. American College of Chest Physician
7. Taiwan Lung Cancer Society
8. Taiwan Society for Vascular Surgery
Research Interest:
1. Natural orifice transluminal endoscopic surgery
2. Tracheal surgery (http://www.vascular.idv.tw/chest/)
3. Thoracoscopic Surgery (Video-assisted thoracic surgery)
4. Lung Transplantation
Honors and Awards:
Invited as Editorial Board & Guest Reviewer:
1. Chest
2. European journal of cardiothoracic surgery
3. Asian Cardiovascular & Thoracic Annals
4. Respirology
5. Journal of the Formosan Medical Association
Curriculum vitae
Sanghoon Jheon, M.D., Ph.D. (錢 相 勳)
Current position;
Professor and Chairman,
Department of Thoracic and Cardiovascular Surgery
Seoul National University College of Medicine, Seoul, Korea.
Chief Financial & Strategy Officer,
Seoul National University Bundang Hospital, Korea.
Visiting Professor,
Department of Surgery,
Tokyo Medical University, Tokyo, Japan
Education and affiliation
1984, Graduate @ Kyungpook National University School of Medicine, Korea
1994, Ph.D.
1984-1989
Residency in Thoracic and Cardiovascular Surgery
at Kyungpook National University Hospital, Korea
1990-1993
Medical officer at Korean Army
1993-1994 Chief of Thoracic Surgery, Andong General Hospital
1994-2000
Instructor, Assistant professor, Associate professor
at Kyungpook National University, Korea
2001-2002
Director of Faculty of Medicine
at Catholic University of Daegu, Korea
2003-present Professor
at Seoul National University, Korea
1994
visiting surgeon at National Cancer Center, Japan
1997-1998
fellowship at MGH, Boston, MA, USA
Academic interests; Thoracic surgical oncology, Thoracoscopic surgery,
Clinical trials, Cardiopulmonary physiology, microimaging,
Tissue engineering, Lung cancer screening and smoking cessation
Medical Society Activity;
Member, Academy of Medicine of Korea
President, Asia Thoracoscopic Surgery Education Program(ATEP)
Chairman, Korea-Japan Thoracoscopic Surgery Summit
Founding Chairman, Korean Study Group of Thoracoscopic Surgery
Board member, Korean Association for Thoracic and Cardiovascular Surgery
Board member, Korean Association of Bronchoesophagology
Board member, Korean Association of Photodynamic Therapy
Board member, Asian Thoracic Surgical Club
Member, International Association for the Study of Lung Cancer
Member, International Society of Heart and Lung Transplantation …
CURRICULUM VITAE
Name: Chao, Yin-Kai 趙盈凱
1994~2001 MD; Chang Gung University, Taoyuan, Taiwan
Post-Graduate Education:
2006/9~2011/8 PHD; Graduate Institute of Clinical Medical Sciences, Change Gung University, Taoyuan, Taiwan
Employment Record:
July 2000~June 2001
Aug 2001~Aug 2004
Aug 2004~Aug 2006
July 15~31, 2006
Aug 2006~
July 2008~June 2011
Aug 2009~
July 2011~
Internship, Chang Gung Memorial Hospital
R1, R2 & R3, Div of General Surgery, Chang Gung Memorial Hospital
Fellow, Div of Thoracic & Cardiovascular Surgery, Chang Gung
Memorial Hospital
Fellow, Div of Thoracic Surgery, National Cancer Center, Tokyo, Japan
Attending Staff, Div of Thoracic & Cardiovascular Surgery, Chang Gung
Memorial Hospital
Lecturer, Div of Thoracic & Cardiovascular Surgery, CGMH
Lecturer of Surgery, Chang Gung University
Assistant professor, Div of Thoracic & Cardiovascular Surgery, CGMH
Board Certification:
1.
2.
3.
4.
5.
Taiwan Surgical Association
Taiwan Association of Thoracic & Cardiovascular Surgery.
Taiwan Society of Pulmonary and Critical Care Medicine
Taiwan Society of Critical Care Medicine
Taiwan Society for Vascular Surgery
Professional Affiliations:
1. Taiwan Surgical Association
2. Taiwan Association of Thoracic & Cardiovascular Surgery
3. Taiwan Society of Pulmonary and Critical Care Medicine
4. Taiwan Society of Critical Care Medicine
5. Taiwan Society for Vascular Surgery
Research Interest:
1. Cardiovascular and Thoracic Surgery
2. Thoracic Oncology (Esophageal cancer)
CURRICULUM VITAE
Name :
ANTHONY PING-CHUEN YIM
Title:
Private Practice
Honorary Clinical Professor
Institution /
Organization:
Minimally Invasive Thoracic Surgery
Centre
The Chinese University of Hong
Kong
Qualifications:
Bachelor of Arts (Cambridge) with Double First Class Honours
1981
(Medical Science Tripos, Part II in Pathology)
Bachelors of Medicine and Surgery (Oxford)
1984
Master of Arts (Cambridge)
1985
Master of Arts (Oxford)
1985
Diploma of the American Board of Surgery
1992
Cardiothoracic Surgery Board (The College of Surgeons of Hong Kong)
1994
Specialist Registration (Cardiothoracic Surgery)
(Medical Council of Hong Kong Ref. No. S31-0010)
1997
Fellow of the Royal College of Surgeons of Glasgow FRCS by election
1997
Fellow of the Royal College of Surgeons of England ad eundem
1998
Fellow of the Royal College of Surgeons of Edinburgh (without examination)
1998
Doctor of Medicine (Oxford)
1999
Membership / Fellowship of Learned Societies:
1.
American Association for Thoracic Surgery (AATS)
2.
The Society of Thoracic Surgeons
3.
General Thoracic Surgery Club
4.
American College of Chest Physicians (FCCP)
5.
American College of Surgeons (FACS)
6.
The American Thoracic Society
7.
European Association for Cardio-Thoracic Surgery (EACTS)
8.
American Heart Association
9.
Hong Kong Academy of Medicine (FHKAM)
10.
The New York Academy of Sciences
11.
The College of Surgeons of Hong Kong (FCSHK)
12.
The International College of Surgeons
13.
The University of Chicago Surgical Society (Life member)
14.
The Society of Laparoendoscopic Surgeons
15.
Hong Kong Surgical Laser Association
16.
International Association for Cardiac Biological Implants
17.
International Society of Cardiothoracic Surgeons (ISCTS)
18.
Pan-Pacific Surgical Association
19.
American Association For The Advancement of Science (AAAS)
20.
The Endoscopic and Laparoscopic Surgeons of Asia (ELSA)
21.
Chinese Medical Association-Subspecialty Membership in Cardiothoracic Surgery
22.
Fellow of the International Biographical Association (FIBA)
Awards and Distinctions at University and Medical School:
At Cambridge
Queens' College Exhibition
1980
Queens' College Prize
1980
Mosseri Prize for Distinction in Physiology
1980
Queens' College Foundation Scholarship
1981
Queens' College Prize
1981
Melsome Memorial Prize for the Most Outstanding Graduate in Natural Sciences
1981
Dr. A.M. Barrett Memorial Prize for Research in Pathology
1981
At Oxford
Hobson Memorial Entrance Scholarship to the Clinical School
1981
Brian Johnson Prize in Pathology
1982
Green College Scholarship
1982
W.T. Lee Travel Scholarship to Hong Kong
1984